european psychiatric association

Advocacy

In recent years, the EPA consolidated its role as a key stakeholder in the EU policy arena and strengthened its advocacy activities to contribute to the development of evidence-based policies in the field of mental health. Since the opening of the EPA Brussels office in 2015, the EPA made major efforts to consolidate its role as the main Association for psychiatry in Europe.

In particular, the EPA strengthened the role of the EPA Council of NPAs  and build strategic partnerships with other actors active in the field of mental health, such as the patient and family organisations.

Key achievements included:

  • Official representation of patient organisation GAMIAN-Europe and family organisation EUFAMI in the EPA Board
  • Joint policy events such as the EPA Forum in Nice entitled “Person-centred mental health care: outcomes that matter to patients and their carers” and the EPA-GAMIAN Europe meeting at the European Parliament on “New horizons for person-centred research and care”, as part of the work of the European Parliament Interest Group on Mental Health, Wellbeing and Brain Disorders
  • Key advocacy work in partnership with the European Brain Council (EBC) around brain and mental health related research, and with GAMIAN-Europe on patient empowerment